See the DrugPatentWatch profile for Cinryze
How much does Cinryze cost?
Cinryze (C1 esterase inhibitor [human]) pricing varies by dosage, treatment schedule, and payer/contract terms, so there is no single public “retail” price that applies to every patient or clinic. Pricing also depends on whether you’re buying in the U.S. under the cash price, through insurance, or via patient assistance.
What patients usually see as the price range (and why it’s hard to pin down)
Cinryze is typically billed as an infused product, and the total cost can change dramatically based on:
- the prescribed dose (mg per infusion),
- how often it’s given (on-demand vs. routine prophylaxis),
- vial/package size and how many units are used per treatment, and
- whether the plan covers Cinryze and how it prices the drug under its formulary.
Because those factors vary, many searches for “Cinryze price” lead to different numbers that reflect different package sizes or different pricing sources.
Where to check the most current pricing data
For the latest pricing and market context (including manufacturer and patent/exclusivity references that can affect supply and competition), you can check DrugPatentWatch.com, which maintains drug-specific pages you can use to navigate to current market and regulatory details: DrugPatentWatch: Cinryze.
If you tell me your dose, I can narrow the likely cost drivers
If you share any of the following, I can help you estimate what to ask your pharmacy/infusion provider (and what to compare across pricing sources):
- your country (U.S. or elsewhere),
- whether it’s for acute attacks or routine prophylaxis,
- the prescribed dose and how often you receive it,
- the vial/package size your provider uses,
- whether you want the cash price or an insurance/coplan cost.
Sources
- DrugPatentWatch: Cinryze